Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

d-Tubocurarine °ú¹Î¼º¹ÝÀÀ

d-tubocurarine Anaphylaxis

´ëÇѸ¶Ãë°úÇÐȸÁö 1977³â 10±Ç 1È£ p.71 ~ 73
±èÀçÈ­, ¼­¼ø¸², ±è¹ÌÇÑ,
¼Ò¼Ó »ó¼¼Á¤º¸
±èÀçÈ­ (  ) - °æºÏ´ëÇб³ Àǰú´ëÇÐ ¸¶Ãë°úÇб³½Ç
¼­¼ø¸² ( Suh Soon-Rim ) - °æºÏ´ëÇб³ Àǰú´ëÇÐ ¸¶Ãë°úÇб³½Ç
±è¹ÌÇÑ ( Kim Mi-Han ) - °æºÏ´ëÇб³ Àǰú´ëÇÐ ¸¶Ãë°úÇб³½Ç

Abstract


Numerous reports of anaphylactoid reaction to d-tubocurarine have appeared since 1936. Also it has been suggested that histamine released as a consequence of clinical doses of d-tubocurarine is not in sufficient quantity to evoke symptoms. We recently had experience with a case who had of severe circulatory collapse and urticarial reaction while being anesthetized with ether and d-tubocurarine. This report draws attention to the risk of administering histamine releasing drugs and references are reviewed.

Ű¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS